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BACKGROUND: Analgesic exposure during pregnancy may aﬀect aspects of fetal gonadal development that are targeted by endocrine disruptors.
OBJECTIVES:We investigated whether therapeutically relevant doses of acetaminophen and ibuprofen aﬀect germ cell (GC) development in human fe-
tal testes/ovaries using in vitro and xenograft approaches.
METHODS: First-trimester human fetal testes/ovaries were cultured and exposed to acetaminophen or ibuprofen (7 d). Second-trimester human fetal
testes were xenografted into mice and exposed to acetaminophen (1 or 7 d), or ibuprofen (7 d). To determine mechanism of action, a human GC
tumor–derived cell line (NTera2) exhibiting fetal GC characteristics was used in addition to in vitro and in vivo rat models.
RESULTS AND DISCUSSION: Gonocyte (TFAP2C+ ) number was reduced relative to controls in ﬁrst-trimester human fetal testes exposed in vitro to
acetaminophen (–28%) or ibuprofen (–22%) and also in ovaries exposed to acetaminophen (–43%) or ibuprofen (–49%). Acetaminophen exposure
reduced gonocyte number by 17% and 30% in xenografted second-trimester human fetal testes after treatment of host mice for 1 or 7 d, respectively.
NTera2 cell number was reduced following exposure to either analgesic or prostaglandin E2 (PGE2) receptor antagonists, whereas PGE2 agonists pre-
vented acetaminophen-induced reduction in NTera2 cell number. Expression of GC pluripotency genes, and genes that regulate DNA/histone methyl-
ation, also diﬀered from controls following analgesic and PGE2 receptor antagonist exposures. Gene expression changes were observed in rat fetal
testis/ovary cultures and after in vivo acetaminophen exposure of pregnant rats. For example, expression of the epigenetic regulator TET1, was
increased following exposure to acetaminophen in human NTera2 cells, rat fetal testis/ovary cultures, and in fetal testes and ovaries after in vivo expo-
sure of pregnant rats, indicating translatability across experimental models and species.
CONCLUSIONS: Our results demonstrate evidence of PGE2-mediated eﬀects of acetaminophen and ibuprofen on GC/NTera2 cells, which raises con-
cerns about analgesic use during human pregnancy that warrant further investigation. https://doi.org/10.1289/EHP2307
Introduction
Epidemiological studies support the view that maternal exposure to
certain environmental chemicals with endocrine-disrupting poten-
tial may be associated with adverse eﬀects on reproductive devel-
opment of the resulting oﬀspring, including androgen-dependent
processes in males (Skakkebaek et al. 2016). More recently, ex-
perimental animal evidence suggests that in utero exposures to
endocrine-disrupting chemicals could have intergenerational
eﬀects via epigenetic changes to fetal germ cells (Lane et al. 2015;
Braun et al. 2017). In contrast with unintentional exposure to low
levels of environmental chemicals, pregnant women may be inten-
tionally exposed to relatively high doses of pharmaceuticals—if
medications have reproductive developmental eﬀects, and their use
is associated with environmental exposures, they could confound
associations between in utero environmental chemical exposures
and developmental outcomes in human observational studies. In
this context, data collected from pregnant women in the United
States (Werler et al. 2005), France (Philippat et al. 2011), and
Denmark (Jensen et al. 2010) during the late 1990s to mid-2000s
indicated that the majority (55% in Denmark, 70–76% in the
United States, 89% in France) used an analgesic at least once dur-
ing pregnancy, with most (47–66%) reporting use of acetamino-
phen (paracetamol) and 5–15% reporting use of ibuprofen (a
nonsteroidal anti-inﬂammatory drug; NSAID), both of which are
available without medical prescription (Campbell et al. 2016;
Werler et al. 2005). Acetaminophen and NSAIDS are able to cross
the placenta into the fetal circulation and as a result have the poten-
tial to aﬀect fetal development (Alano et al. 2001; Naga Rani et al.
1989; Nitsche et al. 2017; Weigand et al. 1984).
Epidemiological studies have reported some evidence of
associations between analgesic use during pregnancy and cryp-
torchidism in sons, though ﬁndings have been inconsistent
within and among diﬀerent study populations (Berkowitz and
Lapinski 1996; Jensen et al. 2010; Kristensen et al. 2011;
Philippat et al. 2011; Snijder et al. 2012). Testicular descent is
primarily under the inﬂuence of testosterone produced by the
Leydig cells of the fetal testis, and experimental studies have
shown that the analgesics, acetaminophen, ibuprofen, and aspirin
can all reduce testosterone production by the fetal testis in the rat
(Kristensen et al. 2011, 2012; van den Driesche et al. 2015). A
recent study using a xenograft model of human fetal testis tis-
sue collected between 14–20 gestational weeks reported that
prolonged acetaminophen exposure at a human-relevant dose
(20 mg=kg three times per day for 7 d) decreased plasma tes-
tosterone levels in xenografted mice (van den Driesche et al.
2015). In addition, treatment of pregnant rats with a compara-
ble acetaminophen dose suppressed the expression of speciﬁc
steroidogenic enzymes (Cyp11a1 and CYP17a1) in rat fetal
testes.
Recent studies have investigated analgesic exposure during
pregnancy in relation to fetal germ cell (GC) development and
later reproductive function in rodents (Dean et al. 2016; Holm
et al. 2016). Modiﬁcations in fetal GC might not only aﬀect the
future reproductive potential of the exposed fetus, but could
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potentially aﬀect future generations (intergenerational eﬀects). In
an experimental rat study, gestational exposures to indomethacin
or acetaminophen (single daily doses of 0.8 and 350 mg=kg,
respectively) were associated with a 40–50% reduction in fetal
ovary GC number and signiﬁcant reductions in ovary weight and
fertility in adult Filial 1 (F1) females, whereas exposure to indo-
methacin (an NSAID) was associated with a 43% reduction in
fetal testes GC number (Dean et al. 2016). Moreover, fetal expo-
sure to either analgesic was associated with abnormal ovarian de-
velopment and function in the second generation, independent of
the sex of the exposed F1 parent, suggesting an intergenerational
eﬀect transmitted via both paternal and maternal lines that was
hypothesized to be a consequence of epigenetic changes to the
GCs (Dean et al. 2016).
One mechanistic pathway that potentially links analgesics and
epigenetic alterations is the prostaglandin (PG) pathway, through
which acetaminophen, indomethacin, and ibuprofen can all act.
Somatic and germ cells in the fetal gonads of both sexes in rats
and humans are sources and targets of PGs because they express
the PG-synthesizing COX-2 enzyme and PGE receptors (Bayne
et al. 2009; Dean et al. 2016). Studies have shown that PGE2
exerts a range of eﬀects on normal and cancerous cells, in vivo
and in vitro (Wang and Dubois 2006), including alterations in
cell proliferation (Yun et al. 2009) and stem cell pluripotency
(Wang et al. 2013; Yun et al. 2012). PGE2-induced changes in
DNA and histone methylation are also described and reported to
be mediated by altered expression of key epigenetic regulatory
factors including DNA methyltransferases (DNMT3a and b) and
enhancer of zeste homolog 2 (EZH2) (Arosh et al. 2015; Venza
et al. 2012; Xia et al. 2012).
For the present study, we used a combination of approaches,
including culture and xenografting of human fetal gonads, NTera2
cells, culture, and pregnancy studies in rats, to investigate the
eﬀects of acetaminophen and ibuprofen exposures at human thera-
peutically relevant levels on GC number and pluripotency in the
human fetal testis and ovary, and to determine whether eﬀects
involved the PGE2 pathway and altered the expression of key epi-
genetic regulatory factors.
Materials and Methods
Study Design
We aimed to determine whether exposure to acetaminophen or
ibuprofen aﬀects GC number in fetal human gonads and to exam-
ine the potential mechanisms involved. The eﬀect of common
analgesics was studied in a variety of model systems in vitro and
in vivo. The models and their speciﬁc treatment regimens are
shown in Figure 1. Eﬀects of exposure were studied in human fe-
tal gonads taken from diﬀerent stages of pregnancy using hanging
drop culture (ﬁrst-trimester testes and ovaries) and a xenograft
system (second-trimester testes). Sample sizes (minimum n=3)
were based on those required to achieve statistical signiﬁcance in
previous studies using the same methodology (Mitchell et al.
2012, 2013), and analgesic dose–response analyses were not per-
formed because of the restricted availability of human fetal
samples.
The analgesic concentrations used in cultures (10 lM; Figure
1A) were based on previous studies (Janssen and Venema 1985;
Kristensen et al. 2012; Mazaud-Guittot et al. 2013) and are rele-
vant to peak serum concentrations in humans following therapeu-
tic analgesic exposure reported as 1:37 lM for acetaminophen 48
min after exposure (Rayburn et al. 1986) and 2:5 lM for ibupro-
fen 1 h after exposure (Janssen and Venema 1985). To compare
the eﬀects of treatment versus vehicle in xenografts for each indi-
vidual human fetal testis (Figure 1B), we grafted tissue from each
fetus into three to six replicate host mice and randomly allocated
these to receive either acetaminophen/ibuprofen or vehicle treat-
ment. For the xenograft studies, human-relevant oral doses
administered to host mice were based on the UK maximum rec-
ommended daily dosing of acetaminophen (20 mg=kg three times
daily) and ibuprofen (10 mg=kg three times daily) (https://bnf.
nice.org.uk/drug/paracetamol.html and https://bnf.nice.org.uk/drug/
ibuprofen.html). Previous studies have shown that this dose of
acetaminophen produces a considerably lower plasma concentra-
tion in host mice (1 h post-dose) than that shown in humans
Figure 1. Exposure/treatment regimens and the diﬀerent investigative
models used in the present studies. Each panel shows a diﬀerent experi-
mental model together with the exposure/treatment (colored circles) regi-
men employed, including timescale. (A) Hanging drop culture of ﬁrst-
trimester human fetal testes and ovaries. Medium was supplemented with
hCG (0:1 U=mL daily). (B) Xenografts of second-trimester human fetal
testes grafted into nude mice. Note experimental treatments commenced 7
d after grafting in order to allow vascularization of the grafts. hCG (20 IU)
was administered to host mice by subcutaneous injections every 72 h. (C)
NTera2 (testicular germ cell tumor cell line) cell culture. Tissue cultured
for 2 d (days 0–2) followed by analysis (indicated by “X”). (D) Hanging
drop culture of fetal, embryonic day 15.5 (e15.5), rat testes and ovaries.
Tissue cultured for 2 d (days 0–2) followed by analysis (indicated by “X”).
(E) In vivo exposure of fetal rat testes and ovaries by treatment of pregnant
rats from e13.5 until e15.5 or e17.5. The order of panels corresponds with
the order of models presented in the “Results” section. Note: Acet, acet-
aminophen; hCG, human chorionic gonadotropin; Ibu, ibuprofen.
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(0:94 lg=mL vs. 20:8 lg=mL) (van den Driesche et al. 2015;
Rayburn et al. 1986).
Experiments to determine the mechanism of analgesic action
used a GC tumor–derived cell line (NTera2), and end points eval-
uated included cell number, proliferation status, and expression
of pluripotency markers and epigenetic regulators (Figure 1C). In
addition, we used hanging drop cultures of rat fetal gonads to
investigate whether similar eﬀects were found in a rat model
(Figure 1D). For human fetal gonad cultures, analgesic doses
were 10 lM for both acetaminophen and ibuprofen. For in vivo
rat studies (Figure 1E), pregnant dams were randomly allocated
to receive either acetaminophen (350 mg=kg per day) or vehicle
via oral administration. We previously reported that serum levels
in pregnant rats 1 h after oral dosing with 350 mg=kg per day
were 49:4± 13:9 lg=mL and undetectable in controls (Dean et al.
2016).
Animals
All aspects of animal housing, management, and treatment con-
formed to UK Home Oﬃce guidelines. Wistar rats (Charles River)
were housed under standard conditions and CD1 nude mice
(Charles River) were housed in individually ventilated cages. All
animals had free access to tap water and soy-free diet (SDS). All
animals, including the mice used for xenotransplantation were
handled with care to avoid unnecessary pain and suﬀering. For rat
studies, timed matings were established by the presence of a vagi-
nal plug, deﬁned as embryonic day 0.5 (e0.5).
Human Fetal Gonad Hanging Drop Cultures
Culture of ﬁrst-trimester human fetal testes [n=5; 8–11 gesta-
tional weeks of age (GW)] and ovaries (n=3 9–11 GW) were as
previously described (Jørgensen et al. 2015). For each fetus, the
number of tissue pieces available and the allocation of tissue to
each experiment and analysis were determined by the size of
the starting material. Tissue pieces from both testes of each indi-
vidual fetus were randomly allocated to treatment or control, mak-
ing the fetus the experimental unit. In brief, gonads were cut into
∼ 1-mm3 pieces and cultured individually in hanging drops con-
taining 30-lL Alpha-MEM (Lonza) supplemented with 10% fetal
bovine serum (Life Technologies), 10-lL=mL penicillin/strepto-
mycin (Sigma-Aldrich), 1% 200-mM L-glutamine (100X) (Gibco),
1% MEM NEAA nonessential amino acids (100X) (Gibco), 2%
sodium pyruvate 100mM (100X) (Gibco), and 1% insulin-
transferrin-selenium (100X) (Gibco). Plates were incubated for 8 d
at 37°C under 5% CO2. The medium was changed daily. Samples
were cultured with human chorionic gonadotropin (hCG) alone
during the ﬁrst day, and thereafter the medium was supplemented
with hCG (0:1 U=mL; Pregnyl; Organon Laboratories) plus vehi-
cle (DMSO) or analgesic (10-lM acetaminophen or 10-lM ibu-
profen) for the remainder of the culture period (Figure 1). hCG
was added in order to mimic the in utero environment. Following
culture, tissue samples were ﬁxed in Bouin’s solution (Clin-Tech)
for 2 h for subsequent ﬂuorescence immunohistochemistry.
Human Fetal Testis Xenograft Studies
Previous attempts by our lab using human fetal ovarian tissue
xenografts did not achieve good viability, therefore xenograft
experiments were only performed with testis tissue. Second-
trimester human fetal testis tissue was used for ex vivo xenograft
studies because they provide a more physiological model to study
gonad development and suﬃcient testis tissue to perform the xen-
ografts (Mitchell et al. 2010). Fetal testes (n=10; 14–17 GW)
pieces (∼ 1mm3) were xenografted into castrate male CD1 nude
(host) mice (4–6 wk of age; n=44) as described previously (van
den Driesche et al. 2015). In brief, mice were castrated at least
2 wk before xenografting. Analgesia (Carprofen, Pﬁzer) was
given in the drinking water for 3 d after castration. Four to six
pieces of testis tissue were grafted subcutaneously under the dor-
sal skin of each host mice on either side of the midline. For each
fetus, tissue pieces were grafted into 36 host mice that were
randomly allocated to receive treatment or vehicle. Grafts were
maintained for 7 d, in order to establish a blood supply, fol-
lowed by 1 d (acetaminophen) or 7 d (acetaminophen, ibupro-
fen) of analgesic exposure (Figure 1B). Host mice also received
subcutaneous injections of 20 IU hCG every 72 h to mimic
the in utero environment (van den Driesche et al. 2015). Host
mice received vehicle (corn oil), acetaminophen (20 mg=kg
three times daily; Sigma-Aldrich) or ibuprofen (10 mg=kg three
times daily; Sigma-Aldrich); both analgesics were suspended in
corn oil and administered by gavage. Host mice were sacriﬁced
by cervical dislocation and grafts were retrieved and weighed
before ﬁxation in Bouin’s solution for subsequent ﬂuorescence
immunohistochemistry. Blocks (one to two per host mouse)
were randomly selected for immunohistochemical analysis and
quantiﬁcation of GC number and proliferation as described
below.
Cell Culture
NTera2 cells (gift from P. Andrews; passages 25–35) were used
to study potential mechanisms of analgesic action on GC. We
chose NTera2 cells, a pluripotent human embryonal carcinoma
cell line derived from an adult testicular GC cancer patient
because they express markers of fetal GC, such as TFAP2C and
hence they are commonly used as a fetal GC model (Hoei-
Hansen et al. 2004). For expansion, cells were cultured in
DMEM medium (Life Technologies), supplemented with 10% fe-
tal calf serum (Life Technologies), 1% penicillin/streptomycin
(Sigma-Aldrich) and 1% L-glutamine (Gibco). Cell cultures were
washed with phosphate-buﬀered saline (PBS) (Life technologies),
and disaggregated with TRypLE™ Express (Gibco). Cells were
cultured at 37°C under 5% CO2 and split 1:2 or 1:4 for passage
when conﬂuent. Cell-conditioned media were regularly tested for
mycoplasma infection by ELISA (mycoprobe™; R&D Systems®).
For treatment, NTera2 cells (200,000/well) were cultured for 48 h
at 37°C under 5% CO2. The medium was supplemented with either
vehicle (DMSO), 10- or 50-lM acetaminophen, 10-lM ibuprofen,
or 10-lM L-161,982 (EP2 antagonist, Caymanchem) + 10-lM
PF04418948 (EP4 antagonist, Caymanchem) (Figure 1C).
For analysis with EP2+EP4 agonists, NTera2 cells (exclud-
ing vehicle) were ﬁrst exposed to 10-lM Butaprost (EP2 agonist;
Abcam) plus 10-nM CAY10598 (EP4 agonist; Abcam) for 4 h
before the medium was changed to the subsequent treatment as
follows: EP2+EP4 agonists, 10-lM acetaminophen or the com-
bination of 10-lM acetaminophen+EP2+EP4 agonists (Figure
1C) and cultured for a further 44 h (total duration of culture: 48
h). After treatment, cells were either disaggregated with TRypLE
for cell counting or protein analysis (ELISA), or collected for
gene expression with Trizol (Life Technologies). All experiments
were repeated three times, except the recovery experiment (using
EP2+EP2 agonists together with acetaminophen), which was
repeated four times. Cell number (including both viable and dead
cells) was determined using a NucleoCounter® (Chemometec)
according to manufacturer’s guidelines, which involved resus-
pension of disaggregated cells in lysis and stabilization buﬀers
(Chemometec). Cell death was determined from the same sam-
ples by ﬂow cytometry. Propidium iodide (75 lM; BD bioscien-
ces) was added to disaggregated cells to identify dead cells,
which were quantiﬁed by ﬂow cytometry (Flow Analyzer 5L
LSR Fortessa; BD).
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Rat Fetal Gonad Hanging Drop Cultures
Rat fetal (e15.5; n=13–30, from 20 litters) testes and ovaries
were cut into ∼ 1-mm3 pieces and cultured as described above
for human hanging drop cultures. Culture was for 48 h with ei-
ther vehicle, acetaminophen (10 lM), ibuprofen (10 lM), or L-
161,982 (EP2 antagonist; 10 lM) + PF0441848 (EP4 antago-
nist; 10 lM) (Figure 1D). Samples were then ﬁxed in Bouin’s
solution for immunohistochemistry or snap-frozen for gene
expression analysis.
Rat in vivo Pregnancy Studies
Pregnant female rats (n=11) were administered acetaminophen
(350 mg=kg per day by oral gavage) suspended in corn oil from
e13.5 until the day before sampling (e15.5 or e17.5), as described
previously (Dean et al. 2013, 2016) (Figure 1E). This dose equa-
tes to a human equivalent dose of ∼ 60 mg=kg (i.e., typical daily
consumption in humans) based on calculation of body surface
area (Reagan-Shaw et al. 2008), and has been shown to be non-
toxic, based on previous ﬁndings that this dose was not associated
with a reduction in the weight of dams or their pups (van den
Driesche et al. 2015). Control dams (n=10) were administered
corn oil according to the same regimen. After treatment, rats
were sacriﬁced by cervical dislocation and fetal gonads were dis-
sected and frozen for gene expression analysis.
Fluorescence Immunohistochemistry
Fluorescence immunostaining was used to identify Sertoli cells
(SOX9; Merck, Millipore; catalog no. AB5535) and GC subpopula-
tions, namely gonocytes (TFAP2C; Santa Cruz Biotechology; cata-
log no. sc-12762) and prespermatogonia (MAGEA4; gift from G.
Spagnoli). Proliferative GC were identiﬁed by co-immunostaining
for Ki67 (Abcam; catalog no. ab16667), and apoptosis was studied
using Cleaved caspase (Cell Signaling Technologies; catalog no.
9661). All samples from the same experiment were stained in the
same run. Sections (5 lm) were dewaxed in xylene and rehydrated
using graded ethanol series. Sections were then subjected to antigen
retrieval by pressure-cooking in 0:01-M citrate buﬀer (pH 6.0) for
30 s at 125°C, followed by 20 min in the decloaking chamber; and
then incubated in 3% (vol/vol) hydrogen peroxide (VWR chemi-
cals) in methanol (Fisher Chemical). Sections were then washed
with Tris-buﬀered saline [TBS: 0:05-M Tris, 0.85% NaCl (pH 7.4)]
and incubated for 30 min with 20% chicken serum, 5% bovine se-
rum albumin (BSA) (Sigma) in TBS to block nonspeciﬁc binding
of the antibodies. Slides were then incubated with primary antibody,
diluted in TBS, in a humidiﬁed chamber overnight at 4°C; followed
by incubation with the appropriate secondary antibody IgG conju-
gated to horseradish peroxidase (HRP; Santa Cruz Biotechnology),
at a concentration of 1:200 in TBS for 30 min at room temperature.
Sections were then incubated for 10 min with Tyramide (TSA Plus
Cyanine 3 System, PerkinElmer Life Sciences) according to the
manufacturer’s instructions.
For double/triple immunohistochemistry, for each subsequent
primary antibody, sections underwent further antigen retrieval by
boiling in 0:01-M citrate buﬀer (pH 6.0) for 2 min in a decloak-
ing chamber, followed by blocking, overnight incubation with
the primary antibody, and incubation with the appropriate sec-
ondary antibody and Tyramide, as described above. In some
cases, this step was followed by a ﬁnal incubation with the nu-
clear counterstain, Hoechst (Thermo Fisher), diluted 1:4,000 in
TBS for 10 min. Slides were washed in TBS and mounted
(Permaﬂuor; Beckman Coulter). Images were acquired using a
Provis microscope (Olympus Optical) ﬁtted with a DCS330 digi-
tal camera (Eastman Kodak).
Quantification of GC Number and GC Proliferation in
Human Fetal Gonads
Fetal testis sections (one per cultured or xenografted tissue pi-
ece) were co-immunostained for sex-determining region Y-box
9 (SOX9; Sertoli cells), transcription-factor activating enhancer-
binding protein 2 (TFAP2C; gonocytes), and melanoma-associated
antigen 4 (MAGEA4; prespermatogonia). The number of cells
from each cell population was counted manually and the relevant
area determined (using ZEN software; ZEISS) by a single observer
blinded to treatment. Three diﬀerent GC populations were quanti-
ﬁed: total GC (TFAP2C+ +MAGEA4+ ), TFAP2C+ GC, and
MAGEA4+ GC. Small pieces of fetal testicular and ovarian tissue
were used for culture, so analysis of GC number had to take
account of seminiferous cord area (ﬁrst-trimester testis culture),
Sertoli cell number (second-trimester testis xenografts), or ovarian
area (ﬁrst-trimester ovary culture), which varied between samples.
The total number of TFAP2C+ and MAGEA4+ GC per section
was expressed relative to the relevant area in micrometers squared
or cell number in that section, such that ratios were determined
for total GC (TFAP2C+ +MAGEA4+ ), TFAP2C+ GC and
MAGEA4+ GC. For quantiﬁcation of GC proliferation, sec-
tions were immunostained for TFAP2C, MAGEA4, and Ki-67.
Proliferative GC (Ki67+ ) were quantiﬁed for TFAP2C+ GC
in ﬁrst-trimester samples and for TFAP2C+ GC and total GC
(TFAP2C+ or MAGEA4+ ), on second-trimester samples, as a
proportion of proliferative TFAP2C+ GC or GC divided by the
total number of GC. Total GC proliferation was not calculated
because MAGEA4+ GC proliferation in ﬁrst-trimester fetal testes
were insuﬃcient to enable meaningful statistical analysis.
For fetal ovary analyses, sections (one per cultured piece) were
co-immunostained for TFAP2C (to identify all GC) and Hoechst
as a counterstain. The total number of TFAP2C+ GC per section
was quantiﬁed and expressed relative to the total tissue section area
(TFAPC2+ GC per micrometer squared). Proliferative TFAP2C+
GC (Ki67+ ) were quantiﬁed as described for fetal testes.
Gene Expression Analysis
RNA extraction was performed using the RNeasy® Micro Kit
(Qiagen) according to manufacturer’s instructions. For hanging
drop cultures, all tissue pieces from each gonad were pooled. For
in vivo rat studies, both ovaries from the same fetus were pooled,
whereas a single testis from each fetus yielded suﬃcient cDNA
for analysis. For NTera2 cells, the RNA phase of the Trizol was
separated and extracted using RNeasy® Micro Kit. RNA was
converted into cDNA using a Vilo kit (Invitrogen) according
to the manufacturer’s instructions. Gene expression analysis
from the cDNA was performed using the Applied Biosystems
Taqman™ RT kit (Applied Biosystems). Quantitative real time
polymerase chain reaction (qRT-PCR) was performed using the
ABI Prism Sequence Detection System (Applied Biosystems).
Expression of epigenetic regulators in human (TET1, EZH2,
DNMT3a, DNMT3b) and rat (Tet1, Ezh2, Dnmt3a and Dnmt3b),
in addition to germ cell pluripotency (POU5F1, TFAP2C and
NANOG) genes were determined using the Roche Universal
Probe Library (Roche Applied Sciences) (see “NTERA2—primer
sequences for gene expression analysis” in the Supplemental
Material for primer sequences). The ribosomal 18S internal con-
trol (Applied Biosystems) and the transcription factor TATA-
binding protein (TBP) (NTera2 cell analysis only) were used as
reference genes to correct the expression of the gene of interest.
All samples were analyzed in duplicate. It was not possible to an-
alyze Dnmt3a and Dnmt3b expression for in vitro rat gonad cul-
tures (acetaminophen or ibuprofen) or in vivo rat fetal testes
(e15.5 or e17.5) or ovaries (e17.5) because these experiments
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were conducted prior to the assessment of Dnmt genes and no
further tissue/mRNA was available.
H3K27me3 ELISA
Treated NTera2 cells (n=3 experiments, each in triplicate) were
collected and crude histones extracted using the trimethylated
lysine 27 at histone 3 (H3K27me3) ELISA kit (Active Motif)
according to manufacturer’s instructions. ELISA plates were
pre-coated with an H3 antibody. H3K27me3 standards and the
extracted crude histones from each sample were added to the
appropriate well. After incubation, the primary antibody was
added and incubated for 1 h. A secondary HRP conjugated anti-
body was then added followed by incubation for 1 h. The colori-
metric reaction was initiated with a developing solution, which
reacts with the HRP conjugate and produces a colorimetric signal.
The reaction was stopped after 5 min by adding a stop solution to
all wells. All samples were determined in duplicate. Absorbance
was measured using a spectrophotometer (LabSystems; 450 nm
wavelength). Known H3K27me3 standards were used to construct
a standard curve, which was used to calculate total H3K27me3 per
well. Total H3K27me3 per sample was expressed relative to the
total protein concentration determined by the Bradford method
(Thermo Fisher).
Statistics
For human fetal gonad cultures and xenograft studies, results were
analyzed by two-factor ANOVA with replication. This enabled us
to account for interindividual variation between fetuses a well as
variation between tissue pieces or xenografts (= the replicates)
from the same fetus, as previously described (Mitchell et al. 2012).
For xenografts, all tissue pieces from the same fetus were treated
as replicates, irrespective of which host mouse they derived from
because variation between xenografts within and between hosts for
the same fetus were comparable, and it was considered that this
method of analysis enabled the most accurate measure of
intrinsic variability (or error) in the xenograft model. Results
for NTera2 cell studies were also analyzed by two-factor
ANOVA with replication, taking account of repeat experiments
(n=3) and replicates (n=3) within each experiment. For rat
in vivo and in vitro studies, analysis was performed using
paired (in vitro) or unpaired (in vivo), two-tailed t-tests.
p<0:05 was used to determine signiﬁcance.
Ethics Statement
Human fetal testes were obtained after elective termination
of pregnancy, according to the Declaration of Helsinki–Ethical
Principles for Medical Research Involving Human Subjects.
Ethical approval for the study was obtained from the South East
Scotland Research Ethics Committee (reference no. LREC08/
S1101/1). Women gave written informed consent. Animal studies
received speciﬁc approval by the UK Home Oﬃce (PPL 60/4564),
including ethical approval, and were performed according to the
Animal (Scientiﬁc Procedures) Act 1986.
Results
Effects of 7-d Acetaminophen or Ibuprofen Exposure on GC
in Hanging Drop Cultures of First-trimester Human Fetal
Gonads
Analgesic eﬀects during human pregnancy may depend on the
gestational period (Kristensen et al. 2011; Snijder et al. 2012), so
we investigated eﬀects in ﬁrst and second-trimester fetal gonads.
GC eﬀects during the ﬁrst trimester were investigated using
hanging drop culture (Jørgensen et al. 2015), in which testis and
ovary samples were exposed to vehicle or analgesic (acetamino-
phen or ibuprofen; each 10 lM) for 7 d (Figure 1A). Cultured tis-
sue pieces appeared healthy. GC ratios were calculated using
TFAP2C+ (gonocytes) and MAGEA4 (prespermatogonia; testis
only) as GC markers, and SOX9 to mark Sertoli cells (see Figure
S1A–C) in testes.
Relative to vehicle controls, acetaminophen-treated testicular
tissue had signiﬁcantly lower numbers of total GCs (–18%; Figure
2A,B) and gonocytes (–28%; Figure 2C,D). Ibuprofen treated tis-
sue had signiﬁcantly fewer gonocytes than controls (–22%; Figure
2C,D), but the reduction in total GCs was not signiﬁcant (Figure
2A,B). MAGEA4+ GC numbers in ﬁrst-trimester fetal testes
were insuﬃcient to enable meaningful statistical analysis (data not
shown). Apoptotic cells (cleaved caspase 3+ ) were rare (see
Figure S2A–C) across all treatments, so quantiﬁcation was not
performed. Proliferating (Ki67+ ) TFAP2C+ gonocytes (Figure
S1D) also were signiﬁcantly reduced in testis tissue exposed to
acetaminophen (–22%) or ibuprofen (–28%) relative to controls
(Figure 2E,F), consistent with a reduction in proliferation versus
an increase in apoptosis as the underlying cause of analgesic-
induced reduction in gonocyte numbers (Figure 2C,D).
In fetal human ovary cultures, numbers of TFAP2C+ GC
were signiﬁcantly reduced in tissue exposed to acetaminophen
(–43%) or ibuprofen (–49%) relative to controls (Figure 3A,B).
Apoptotic cells were rare across all treatments (see Figure S2D–
F). Relative to controls, ovarian TFAP2C+ GC proliferation was
signiﬁcantly reduced after culture with acetaminophen (–25%) or
ibuprofen (–35%) (Figure 3C,D).
Effect of 7-d Acetaminophen or Ibuprofen Exposure on GC
in Second-trimester Human Fetal Testis Xenografts
Second-trimester testis tissue was xenografted into nude mice as
described previously (van den Driesche et al. 2015). Treatment of
host mice with acetaminophen or ibuprofen for 7 d (Figure 1B) sig-
niﬁcantly reduced total GC number (TFAP2C+ + MAGEA4+ )
in xenografts by 43% (Figure 4A,B) and 53% (Figure 4C,D),
respectively, in comparison with vehicle-treated hosts. For
acetaminophen- and ibuprofen-exposed samples, this reduction
appeared to be mainly due to a reduction in TFAP2C+ GC, [for
acetaminophen-exposed tissue, −32% (Figure 4E,F); for ibuprofen-
exposed tissue, −60% (Figure 4G,H)], although this reduction was
signiﬁcant only for acetaminophen. MAGEA4+ GC number
was also reduced following 7 d of acetaminophen or ibuprofen expo-
sure, though not signiﬁcantly [–50% (see Figure S3A,B); and −43%
(see Figure S3C,D), respectively]. Proliferation of total GC was
reduced after 7 d of acetaminophen (−40%; Figure 5A,B) and ibu-
profen exposure (−21%; Figure 5C,D), but this was not signiﬁcant.
Similarly, proliferation of TFAP2C+ GC was reduced after 7 d of
acetaminophen or ibuprofen exposure, but not signiﬁcantly [−34%
(Figure 5E,F); and−20% (Figure 5G,H), respectively].
Effect of 1-d Acetaminophen Exposure on GC in
Second-trimester Human Fetal Testis Xenografts
As acetaminophen use in pregnancy may be mainly for short
periods (≤24 h), we investigated whether 1-d exposure to acet-
aminophen, followed by 6 d of vehicle treatment altered GC
number (Figure 1B). This exposure led to a signiﬁcant reduction
in total GC (22%; Figure 6A,B) and TFAP2C+ GC number
(17%; Figure 6C,D) in xenografts, although the reduction was
less pronounced compared with that seen after 7-d acetamino-
phen exposure (Figure 4A,B and E,F). MAGEA4+ GC number
was not signiﬁcantly altered by 1-d acetaminophen exposure (see
Figure S3E–F). GC proliferation (total or TFAP2C+ ) was
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Figure 2. Eﬀect of analgesic exposure of ﬁrst-trimester fetal human testis tissue for 7 d in hanging drop culture on germ cell (GC) number. Testis tissue pieces
(∼ 1mm3) from ﬁve fetuses (8–11 GW) were cultured for 7 d with vehicle, acetaminophen (A; 10 lM) or ibuprofen (I; 10 lM) (1–4 pieces from each fetus
per treatment). Tissue was immunostained to distinguish Sertoli cells (SOX9+ ), undiﬀerentiated GC (TFAP2C+ ) and diﬀerentiated GC (MAGEA4+ ), and
GC counts were determined within a 1-lm2 ﬁeld of SOX9+ tubule cells. Proliferating GC were identiﬁed by additional staining for Ki67, and the percentage
of proliferating TFAP2C+ cells was determined by dividing all proliferative TFAP2C+ by the total number of TFAP2C+ . (A) Individual data points repre-
sent total GC counts (TFAP2C+ +MAGEA4+ cells) for each 1-lm2 tissue piece per treatment and fetus, with horizontal lines indicating the mean for each
treatment and fetus. (B) Mean ( ±SEM) total GC counts over all tissue pieces and fetuses for each treatment. (C) Individual data points represent TFAP2C+
GC counts for each tissue piece per treatment and fetus, with horizontal lines indicating the mean for each treatment and fetus. (D) Mean (±SEM) TFAP2C+
GC counts over all tissue pieces and fetuses for each treatment. (E) Individual data points represent the percentage of proliferating Ki67+ TFAP2C+ GC in
each tissue piece per treatment and fetus, with horizontal lines indicating the mean for each treatment and fetus. (F) Mean ( ±SEM) percentage of Ki67+
TFAP2C+ cells over all tissue pieces and fetuses for each treatment. p-Values shown in B, D, and E compare values in treated samples to vehicle controls
using two-factor ANOVA to account for tissue replicates for each fetus and multiple fetuses per treatment. Fetuses 1–5 were 8, 10, 11, 9, and 8 GW of age,
respectively. Note: GW, gestational weeks; Ki67, cellular marker for proliferation; SEM, standard error of the mean.
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reduced after 1-d acetaminophen exposure, but not signiﬁcantly
(−34%, and −34%, respectively; Figure 6E–H).
Effects of Acetaminophen, Ibuprofen, and EP21EP4
Antagonists on NTera2 Cell Number
In view of the eﬀects of analgesic exposure on GC number in
human fetal testis tissue, we utilized NTera2 cells as a more trac-
table system to dissect possible mechanisms of analgesic action.
In addition to investigating eﬀects of acetaminophen and ibupro-
fen on NTera2 cells, we also investigated whether blockade of
PGE2 action via combined exposure to an EP2 (PF-04418948,
10 lM), and an EP4 (L-161,982, 10 lM,) receptor antagonist,
induced eﬀects similar to those of analgesics. NTera2 cells were
exposed to acetaminophen (10 or 50 lM), ibuprofen (10 lM) or
EP2+EP4 antagonists (10 lM each; Figure 1C). All three expo-
sures signiﬁcantly reduced total NTera2 cell number (including
both dead and viable cells) after 48 h, relative to controls (−19%
for 10-lM acetaminophen, −58% for 50-lM acetaminophen,
−17% for ibuprofen, and −27% for EP2+EP4 antagonists;
Figure 7A–C) suggesting that the analgesic-induced decrease in
NTera2 cell number could involve inhibition of the PGE2 path-
way. The percentage of dead NTera2 cells was signiﬁcantly
higher than in vehicle controls following exposure to 10-lM
acetaminophen (2.97% vs. 2.13%) and to EP2+EP4 antagonists
(2.69% vs. 2.16%), but the diﬀerence was more pronounced fol-
lowing treatment with 50-lM acetaminophen (7.42% vs. 2.13%)
(see Figure S4). Thus, we considered 50-lM acetaminophen to
be a toxic dose.
To test whether the acetaminophen-induced decrease in
NTera2 cell number was due to inhibition of the PGE2 pathway,
NTera2 cells were cultured either with acetaminophen (10 lM),
with EP2+EP4 agonists (Butaprost 10lM +CAY10598 10nM)
or with the two treatments combined (Figure 1C). Exposure
to the EP2+EP4 agonists alone slightly reduced NTera2 cell
number, but not signiﬁcantly so (−3:3%; Figure 7D), whereas
cell number was signiﬁcantly reduced by exposure to acetamin-
ophen (−21%; Figure 7D), consistent with previous ﬁndings
Figure 3. Eﬀect of analgesic exposure of ﬁrst-trimester fetal human ovary tissue for 7 d in hanging drop culture on germ cell (GC) number. Ovary tissue pieces
(∼ 1mm3) from three fetuses (9–11 GW) were cultured for 7 d with either vehicle, acetaminophen (A; 10 lM) or ibuprofen (I; 10 lM). Tissue was ﬁxed and
double-immunostained for TFAP2C and Hoechst to count the number of undiﬀerentiated TFAP2C+ GC per 1-lm2 ﬁeld of ovary tissue. In addition, cells
were stained for Ki67 to determine the percentage of proliferating TFAP2C+ cells, which was determined by dividing all proliferative TFAP2C+ by the total
number of TFAP2C+ . (A) Individual data points represent TFAP2C+ GC counts for each individual tissue piece per treatment and fetus, with horizontal lines
indicating the mean for each treatment and fetus. (B) Mean ( ±SEM) TFAP2C+ GC counts over all tissue pieces and fetuses for each treatment. (C)
Individual data points represent the percentage of proliferating Ki67+ TFAP2C+ GC for each tissue piece per treatment and fetus, with horizontal lines indi-
cating the mean for each treatment and fetus. (D) Mean (±SEM) percentage of Ki67+ TFAP2C+ cells over all tissue pieces and fetuses for each treatment.
p-Values shown in B, D, and E compare values in treated samples with vehicle controls using two-factor ANOVA to account replicate tissue pieces for each fe-
tus and multiple fetuses per treatment. Fetuses 6–8 were 9, 11, and 9 GW, respectively. Note: GW, gestational weeks; Ki67, cellular marker for proliferation;
SEM, standard error of the mean.
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(Figure 7A). In contrast, the NTera2 cell count was not signiﬁ-
cantly diﬀerent from controls following coculture with 10-lM
acetaminophen and the EP2+EP4 agonists, indicating that
acetaminophen-induced NTera2 cell loss requires an intact PGE
signaling pathway (Figure 7D).
Effects of Acetaminophen, Ibuprofen, or EP21EP4
Antagonists on Expression of GC Differentiation Markers in
NTera2 Cells
We previously showed that expression of the gonocyte pluripo-
tency marker POU class 5 homeobox 1 (POU5F1 or OCT4)
ended earlier in the fetal testes of rats whose dams were exposed
to 350 mg=kg per day acetaminophen or 0:8 mg=kg per day indo-
methacin than in fetal testes from the oﬀspring of unexposed
dams (Dean et al. 2016). We therefore investigated whether
expression of the established GC pluripotency markers POU5F1,
TFAP2C, and NANOG (Rajpert-De Meyts 2006) diﬀered from
vehicle controls in NTera2 cells cultured with acetaminophen,
ibuprofen, or EP2+EP4 antagonists (10 lM each). Compared
with vehicle controls, expression of POU5F1 and TFAP2C was
signiﬁcantly lower in NTera2 cells following acetaminophen
exposure (Figure 8A), whereas only POU5F1 expression was sig-
niﬁcantly lower following ibuprofen exposure (Figure 8B).
Expression of all three genes was signiﬁcantly lower than vehicle
controls in NTera2 cells cultured with EP2+EP4 antagonists
(Figure 8C).
Effects of Acetaminophen, Ibuprofen, or EP21EP4
Antagonists on Expression of Epigenetic Regulatory Genes
in NTera2 Cells
Previous studies showed intergenerational consequences of in
utero acetaminophen/NSAID exposure in rats (Dean et al.
2016) and other publications demonstrate that PGE2 may fun-
damentally regulate the epigenetic machinery (Arosh et al.
2015; Venza et al. 2012). Therefore, we hypothesized that ex-
posure to acetaminophen, ibuprofen, or EP2+EP4 antagonists
might exert similar eﬀects on epigenetic regulatory genes in
NTera2 cells.
Expression of the DNA methyltransferases DNMT3a and
DNMT3b in NTera2 cells was decreased relative to vehicle
controls following exposure to acetaminophen, ibuprofen, and
the EP2+EP4 antagonists, though the diﬀerence in DNMT3a
Figure 4. Eﬀect of 7 d acetaminophen or ibuprofen exposure of second-trimester fetal human testis tissue xenografts on germ cell (GC) number. Testis tissue
pieces (∼ 1mm3) from four fetuses (acetaminophen) or three fetuses (ibuprofen) were xenografted into nude mice. Host mice were administered vehicle, acet-
aminophen (20 mg=kg, three times daily) or ibuprofen (10 mg=kg, three times daily) for 7 d before xenograft recovery. Tissues were ﬁxed and immunostained
to identify Sertoli cells (SOX9+ ), undiﬀerentiated GC (TFAP2C+ ) and diﬀerentiated GC (MAGEA4+ ). Total GC counts (TFAP2C++MAGEA4+ cells)
and TFAP2C+ GC counts were determined relative to the number of SOX9+ Sertoli cells. (A and C) Individual data points representing total GC counts
(TFAP2C++MAGEA4+ cells) for each 1-lm2 tissue piece per treatment and fetus, with horizontal lines indicating the mean for each treatment and fetus.
(E and G) Individual data points representing TFAP2C+ GC counts for each tissue piece per treatment and fetus, with horizontal lines indicating the mean for
each treatment and fetus. (B, D, F, and H) Means ±SEMs over all tissue grafts for each treatment and fetus. p-Values shown in B, D, F, and H compare values
in treated samples with vehicle controls using two-factor ANOVA to account replicate tissue pieces for each fetus and multiple fetuses per treatment.
Corresponding MAGEA4+ GC counts after 7-d treatments with acetaminophen or ibuprofen are shown in Figure S3A–D. Fetuses 9–15 were 14, 14, 14, 17,
14, 17, and 16 GW respectively. Note: GW, gestational weeks; Ki67, cellular marker for proliferation; SEM, standard error of the mean.
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expression was signiﬁcant for ibuprofen only, whereas the
diﬀerence in DNMT3b expression was signiﬁcant for acetamino-
phen and EP2+EP4 antagonist exposures only (Figure 8D–F).
Expression of TET1, which plays a role in DNA and histone meth-
ylation, was signiﬁcantly increased compared with controls after
all three treatments, whereas expression of EZH2, the enzymatic
component of the PRC2 complex responsible for H3K27me3 his-
tone methylation, was increased relative to controls following ex-
posure to ibuprofen (25% increase) and EP2+EP4 antagonists,
(31% increase) though the diﬀerence was signiﬁcant only for the
latter (Figure 8D–F). However, the relative amount of H3K27me3,
as measured by ELISA, was signiﬁcantly higher than in vehicle
controls after culture of NTera2 cells with acetaminophen, ibupro-
fen, or EP2+EP4 antagonists (Figure 8G).
In vitro and in vivo Effects of Acetaminophen, Ibuprofen, or
EP21EP4 Antagonists on Fetal Rat Gonads
Findings from human fetal gonad cultures and xenografts, and in
vitro studies of the NTera2 human GC tumor–derived cell line,
suggest potential eﬀects of analgesic exposures during pregnancy
that may be mediated by PGE2. We next evaluated the eﬀects of
analgesic exposures and PGE2 antagonists on epigenetic regula-
tory genes using fetal rat ovarian or testicular tissue in hanging
drop cultures, to determine whether ﬁndings were consistent
between human and rat tissues, before proceeding with in vivo
studies using a rat model. Tissue pieces were cultured for 48 h
with or without exposure to acetaminophen (10 lM), ibuprofen
(10 lM), or EP2+EP4 antagonists (10 lM L-161,982 + 10 lM
PF04418948) (Figure 1D). As for NTera2 cells (Figure 8D–F),
Tet1 expression in fetal (e15.5) rat testes and ovaries was consis-
tently increased relative to controls after exposure to any of the
three treatments, although in the case of fetal ovaries, the
ibuprofen-induced increase did not reach statistical signiﬁcance
(Figure 9A–F). Ezh2 expression was higher in testis and ovaries
after exposure to ibuprofen, as in NTera2 cells, but, in contrast
with NTera2 cells, Ezh2 expression was also increased following
exposure to acetaminophen, and was lower than in controls fol-
lowing culture with EP2+EP4 antagonists (signiﬁcant for ovary
cultures). Expression of Dnmt3b was signiﬁcantly lower than
Figure 5. Eﬀect of 7-d acetaminophen or ibuprofen exposure of second-trimester fetal human testis tissue xenografts on germ cell (GC) proliferation. Testis tis-
sue pieces (∼ 1mm3) from four fetuses (acetaminophen) or three fetuses (ibuprofen) were xenografted into nude mice. Host mice were administered vehicle,
acetaminophen (20 mg=kg, three times daily) or ibuprofen (10 mg=kg, three times daily) for 7 d before xenograft recovery. Tissues were ﬁxed and immuno-
stained to identify undiﬀerentiated GC (TFAP2C+ ) and diﬀerentiated GC (MAGEA4+ ), with Ki67 staining to identify proliferating cells. Percentage of pro-
liferating TFAP2C+ cells was determined by dividing all proliferative TFAP2C+ by the total number of TFAP2C+ . (A and C) Individual data points
representing the percentage of proliferating Ki67+ GC for each tissue piece per treatment and fetus, with horizontal lines indicating the mean for each treat-
ment and fetus. (E and G) Individual data points representing the percentage of proliferating Ki67+ TFAP2C+ GC for each tissue piece per treatment and fe-
tus, with horizontal lines indicating the mean for each treatment and fetus. (B, D, F, and H) Mean (±SEM) percentage of Ki67+ GC or TFAP2C+ cells over
all tissue pieces and fetuses for each treatment. p-Values shown in B, D, F, and H compare values in treated samples with vehicle controls using two-factor
ANOVA to account for replicate tissue pieces for each fetus and multiple fetuses per treatment. Fetuses 9–15 were 14, 14, 14, 17, 14, 17, and 16 GW, respec-
tively. Note: GW, gestational weeks; Ki67, cellular marker for proliferation; SEM, standard error of the mean.
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controls after exposure to EP2+EP4 antagonists in both testis
and ovary cultures (Figure 9C,F), whereas expression of Dnmt3a
was signiﬁcantly lower in ovary cultures but slightly higher in
testis cultures, but not signiﬁcantly so (Figure 8C,F). Dnmt3a and
Dnmt3b expression were not evaluated in rat testis or ovary cul-
tures exposed to acetaminophen or ibuprofen.
To provide in vivo evidence for the relevance of the identiﬁed
gene expression changes induced by analgesics in vitro, we used
acetaminophen exposure because this analgesic was more fre-
quently associated with signiﬁcant eﬀects in the human fetal testis
xenografts. Pregnant rats received 350 mg=kg acetaminophen
(equivalent to human dose of ∼ 60 mg=kg based on calculation of
body surface area; Reagan-Shaw et al. 2008) by gavage once daily
from e13.5 until the day before sampling (either e15.5 or e17.5)
(Figure 1E). Similar to the in vitro culture studies, Tet1 expression
was increased relative to controls in both the fetal testis (e15.5 and
e17.5; Figure 10A,B) and ovary (signiﬁcant for e15.5 only; Figure
10C,D). Ezh2 expression was signiﬁcantly higher than in controls
in e17.5 testes (Figure 10B) and e15.5 ovaries (Figure 10C) after
acetaminophen exposure. Expression of Dnmt3a was signiﬁcantly
lower, whereas expression of Dnmt3b was only slightly, but not
signiﬁcantly, than controls in e15.5 ovaries following in-vivo acet-
aminophen exposure (Figure 10C), whereas for in vitro ovary
cultures, the acetaminophen-induced reduction in Dnmt3A and
Dnmt3B expression was signiﬁcant for both genes (Figure 9F).
Dnmt3a and Dnmt3b expression were not evaluated in testis (e15.5
or e17.5) or ovary cultures (e17.5) exposed to acetaminophen or
ibuprofen.
Discussion
Our results show that, under our experimental conditions in our
model systems, exposure to the analgesics acetaminophen and ibu-
profen, at human therapeutically relevant levels, causes signiﬁcant
Figure 6. Eﬀect of 1-d acetaminophen exposure of second-trimester fetal human testis tissue xenografts on germ cell (GC) number and GC proliferation.
Testis tissue pieces (∼ 1mm3) from three fetuses were xenografted into nude mice. Host mice were administered vehicle or acetaminophen (20 mg=kg, three
times daily) for 1 d and xenografts were retrieved 6 d later. Tissues were ﬁxed and immunostained to identify Sertoli cells (SOX9+ ), undiﬀerentiated GC cells
(TFAP2C+ ), and diﬀerentiated GC (MAGEA4+ ), with Ki67 staining to identify proliferating cells. Total GC counts (TFAP2C+ +MAGEA4+ cells) and
TFAP2C+ GC counts were determined relative to the number of SOX9+ Sertoli cells. Percentage of proliferating TFAP2C+ cells was determined by divid-
ing all proliferative TFAP2C+ by the total number of TFAP2C+ . (A) Individual data points represent total GC counts (TFAP2C+ +MAGEA4+ cells) for
each tissue piece per treatment and fetus, with horizontal lines indicating the mean for each treatment and fetus. (B) Mean ( ±SEM) total GC counts over all
tissue pieces and fetuses for each treatment. (C) Individual data points represent TFAP2C+ GC counts for each tissue piece per treatment and fetus, with hori-
zontal lines indicating the mean for each treatment and fetus. (D) Mean (±SEM) TFAP2C+ GC counts over all tissue pieces and fetuses for each treatment.
(E) Individual data points represent the percentage of proliferating Ki67+ GC in each tissue piece per treatment and fetus, with horizontal lines indicating the
mean for each treatment and fetus. (F) Mean (±SEM) percentage of Ki67+ GC. (G) Individual data points represent the percentage of proliferating Ki67+
TFAP2C+ GC in each tissue piece per treatment and fetus, with horizontal lines indicating the mean for each treatment and fetus. (H) Mean (±SEM) percent-
age of Ki67+ TFAP2C+ cells. p-Values shown in B, D, F, and H compare values in treated samples with vehicle controls using two-factor ANOVA to
account for replicate tissue pieces for each fetus and multiple fetuses per treatment. Fetuses 16–18 were 15, 19, and 14 GW, respectively. Note: GW, gesta-
tional weeks; Ki67, cellular marker for proliferation; SEM, standard error of the mean.
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reductions in GC number in both human fetal testes and ovaries, as
well as altering expression of GC diﬀerentiation markers and epi-
genetic regulatory genes in NTera2 cells, a surrogate for fetal
GC. The analgesic-induced reduction in GC (total and
TFAP2C+ ) number in the human fetal testis was evident for
samples from both ﬁrst trimester (in culture) and second trimes-
ter (xenografts), and in the latter could be induced even with a
single day’s treatment with acetaminophen using a human-
relevant therapeutic dose/regimen. Because studies in the United
States (Werler et al. 2005), Germany (Bremer et al. 2017),
France (Philippat et al. 2011), Denmark (Jensen et al. 2010),
Norway (Harris et al. 2017), and Sweden (Wolgast et al. 2017)
and a multi-national study (Europe, North/South America, and
Australia) (Lupattelli et al. 2014) have documented that many
pregnant women may take analgesics (mainly acetaminophen),
the present ﬁndings raise the possibility of fetal germ cell eﬀects
in human pregnancy. This is reinforced by previous studies that
have shown that analgesic exposure of pregnant rodents can
aﬀect the future fertility of newborn females (Dean et al. 2016;
Holm et al. 2016). Our results suggest that the analgesic eﬀects
on fetal GC may be mediated through the PGE2 pathway, and
may aﬀect the expression of key epigenetic regulatory genes.
This raises the possibility that analgesic exposure might alter the
epigenome of fetal GC, potentially aﬀecting the next generation,
as previously demonstrated in the rat (Dean et al. 2016).
Because direct translation of our earlier ﬁndings of adverse
eﬀects of analgesic exposure on fetal GC in the rat (Dean et al.
2016) to the human is not possible, we employed in vitro and ex
Figure 7. Eﬀect of exposure of NTera2 cells to analgesics or prostaglandin E2-receptor modulators on cell number. NTera2 cells (2 × 105; n=3 for A, B and
C, n=4 for D) were cultured for 48 h in medium supplemented with either vehicle (Veh), (A) acetaminophen (10–50 lM), (B) ibuprofen (10 lM), or (C)
PGE2 antagonists [EP-antags: 10 lM L-161,982 (EP2 antagonist) + 10-lM PF04418948 (EP4 antagonist)]. (D) NTera2 cells were cultured with PGE2
EP2+EP4 receptor agonists [EP-ags: 10-lM Butaprost (EP2 agonist) + 10-nM CAY10598 (EP4 agonist)] for 4 h before media were changed to EP2+EP4 re-
ceptor agonists only, acetaminophen (10 lM) only, or acetaminophen +EP2=EP4 agonists (Acet +EP-ags) and cultured for another 44 h. Values shown are
mean±SEM numbers of NTera2 (including both, dead and viable cells) from three independent experiments with three replicates for A, B, and C, and four rep-
licates for D. p-Values compare values in treated samples with vehicle controls using two-factor ANOVA. Corresponding data for the percentage of dead
NTera2 cells following each treatment are shown in Figure S4. Note: ag, agonist; antag, antagonist; SEM, standard error of the mean.
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Figure 8. Eﬀect of exposure of NTera2 cells to analgesics or prostaglandin E2 antagonists on mRNA expression of germ cell (GC) pluripotency markers, epi-
genetic regulatory genes, and overall H3K27me3 levels. NTera2 cells (2 × 105; n ¼ 3) were cultured for 48 h in medium supplemented with vehicle (Veh),
acetaminophen (Acet; 10–50 μM), ibuprofen (Ibu; 10 μM) or EP2þ EP4 antagonists [EP-antags (10-μM L-161,982; EP2 antagonist þ10-μM PF04418948;
EP4 antagonist)]. Results show mRNA expression relative to the vehicle complementary DNA (open bars) for the GC pluripotency markers POU5F1,
TFAP2C, and NANOG (A, C, and E, respectively) and for the epigenetic regulatory genes TET1, EZH2, DNMT3a, and DNMT3b (B, D, and F, respectively) af-
ter exposure of NTera2 cells to acetaminophen (blue), ibuprofen (orange), or EP2þ EP4 antagonists (maroon) (n ¼ 3). (G) Relative amount of H3K273 pres-
ent in the NTera2 cells after culture with the diﬀerent treatments. Graphs show mean±SEM from three independent experiments with three replicates in each
experiment and statistical analysis was by two-factor ANOVA. Note: antag, antagonist; SEM, standard error of the mean.
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vivo (xenograft) model systems using fetal testicular or ovarian
tissue or NTera2 cells. Exposure to either acetaminophen or ibu-
profen at human-relevant concentrations reduced GC/NTera2 cell
number in all of these systems, consistent with previous studies
showing decreased GC number after analgesic exposure during
pregnancy in rodents (Dean et al. 2016; Holm et al. 2016). In the
human fetal testis, in culture (ﬁrst trimester) the eﬀect on GC
number resulted from a reduction in the TFAP2C+ gonocyte
population, whereas in xenografts (second trimester) the reduc-
tion in germ cell number appeared to involve TFAP2C+ and
more diﬀerentiated prespermatogonia (MAGEA4+ ). TFAP2C+
GC in the human fetal testis are highly proliferative (Mitchell
et al. 2010), and our results tentatively suggest that analgesics
most likely induce GC loss via reduced proliferation. In fetal
human ovary cultures, the highly proliferative premeiotic oogonia
(TFAP2C+ ) were reduced in number following analgesic expo-
sure, similar to ﬁndings in the fetal testis. Analgesic targeting of
TFAP2C+ GC may be related to the probable mechanism of an-
algesic action via PGE2, as discussed below, given that the PGE2
pathway is important in modulating proliferation of (pluripotent)
stem cells in various other systems (Hoggatt et al. 2009; Wang
et al. 2013; Xia et al. 2012; Yun et al. 2009; Wu et al. 2017; Ho
et al. 2017).
In the xenograft model, which recapitulates normal human fetal
testis GC development (Mitchell et al. 2010), TFAP2C+ GC num-
ber was signiﬁcantly reduced by a single day’s exposure to acet-
aminophen using a human-relevant exposure regimen. Similarly, in
human fetal gonad cultures, analgesic-induced reduction in GC
number occurred at concentrations that are achieved in blood after
normal human usage of acetaminophen or ibuprofen (Albert et al.
2013; Janssen and Venema 1985; Mazaud-Guittot et al. 2013). The
fact that analgesic exposure consistently induced GC loss in the
human fetal testis and ovary in each model system used, as well as
causing similar GC loss in rats in fetal gonads after analgesic expo-
sure in vivo (Dean et al. 2016), demonstrates that this is a consist-
ent eﬀect. This raises concerns about potential consequences of
analgesic use in human pregnancy and supports the need for further
investigation. In rats, fetal GC reduction in males can be compen-
sated postnatally as the diﬀerentiated GC resume proliferation after
birth (Dean et al. 2016), and it is likely that this would also occur
Figure 9. Eﬀect of exposure of rat fetal gonads to analgesics or prostaglandin E2 antagonists in vitro on mRNA expression of epigenetic regulatory genes.
Testis and ovary tissue pieces (∼ 1mm3) from e15.5 fetal rats were cultured for 48 h with either vehicle (open bars), acetaminophen (blue; 10 lM), ibuprofen
(orange; 10 lM), or EP2+EP4 antagonists [maroon; 10-lM L-161,982 (EP2 antagonist) + 10-lM PF04418948 (EP4 antagonist)]. (A–F) mRNA expression
relative to the vehicle complementary DNA (open bars) for Tet1, Ezh2, Dnmt3a, and Dnmt3b for cultured fetal testes (A–C) or ovaries (D–F) (mean± SEM,
n=13–30). Data were analyzed by paired t-test. Note: antag, antagonist.
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in human males. However, proliferation of GC in the human ovary
is restricted by subsequent entry to meiosis from 9 wk gestation
(Bendsen et al. 2006; Gondos et al. 1986), so that any GC loss after
this period could have long-term consequences for oocyte reserves
and reproductive lifespan (Nelson et al. 2013). In keeping with
this, previous studies in pregnant rats showed that analgesic-
induced decrease in fetal GC number translated into a decrease in
adult ovarian weight and reduced fertility in adulthood (Dean et al.
2016). This might be investigated in humans by relating analgesic
use in pregnancy to serum anti-Müllerian hormone (AMH) concen-
trations in female oﬀspring, given that AMH levels may indicate
oocyte reserves under certain conditions (Dewailly et al. 2014).
A key aim of the present study was to investigate a potential
mechanism for the eﬀects of acetaminophen and ibuprofen on fetal
GC. Both analgesics have established eﬀects on prostaglandin
pathways (Aminoshariae and Khan 2015; Anderson 2008; Van
Hecken et al. 2000). Our in vivo rat studies have shown that anal-
gesic exposure reduces PGE2 levels in fetal gonads (Dean et al.
2016) and fetal GC are PGE2 targets in both rats (Dean et al. 2016)
and humans (Bayne et al. 2009), so we focused on this pathway.
Because isolation and culture of human fetal GC was not feasible,
we used NTera2 cells. These cells derive from a human pluripotent
embryonal carcinoma cell line that expresses markers (e.g.,
TFAP2C, POU5F1, NANOG) similar to pluripotent human fe-
tal GCs (Knower et al. 2007). Our results show that, in our
model systems, analgesic eﬀects on NTera2 cell number and
pluripotency gene expression are mimicked by culturing with
EP2+EP4 receptor antagonists (which block PGE2 action).
Moreover, the acetaminophen-induced decrease in NTera2 cell
number was prevented by concomitant exposure to EP2+EP4
agonists. Thus analgesic eﬀects on NTera2 cells may be medi-
ated via the PGE2 pathway. This is supported by our ﬁnding
that PGE2 antagonism induced a number of gene expression
changes that were comparable to those induced by acetamino-
phen, and to a lesser extent ibuprofen, in both human (NTera2
cells) and rat (fetal gonad) systems.
Our studies with NTera2 cells show that acetaminophen ex-
posure or PGE2 antagonism reduces expression of one or more
GC pluripotency genes (POU5F1, TFAP2C, NANOG). This is
consistent with previous evidence that EP2 antagonism down-
regulates pluripotency genes (Pou5f1, Nanog) in mouse embry-
onic stem cells (Yun et al. 2012), and abundant evidence that
PGE2 regulates proliferation and diﬀerentiation status in numer-
ous stem cell and cancer cell types in vitro and in vivo (Jones
et al. 2010; Wang et al. 2013; Xia et al. 2012; Wang et al. 2015;
Wang and Dubois 2006). Exposure of human fetal testis explants
to ibuprofen was also reported to reduce expression of speciﬁc
germ cell genes involved in pluripotency (POU5F1, LIN28A)
(Ben Maamar et al. 2017), a ﬁnding echoed presently for
POU5F1 in NTera2 cells. In human males, arrested diﬀerentia-
tion of fetal GC has been proposed as the primary pathway to de-
velopment of testicular GC cancer (TGCC), the most common
malignancy among young men 20–40 y of age (Rajpert-De
Meyts 2006; Mitchell et al. 2014). However, analgesic-induced
reduction in expression of pluripotency genes in all of our studies
(this study and Dean et al. 2016), is opposite to what is thought
to underlie the origin of TGCC.
Our present results demonstrate that analgesic exposure varia-
bly induced changes in expression of a number of epigenetic reg-
ulatory genes in NTera2 cells as well as in fetal ovaries and testes
from the rat (in vitro and in vivo). Although these gene expres-
sion changes were not completely consistent, they raise the possi-
bility that the epigenome of exposed fetal GC could be altered by
analgesic exposure, with unknown consequences. This would be
consistent with our previous ﬁnding that fetal exposure of rats to
analgesics results in intergenerational transmission of reproduc-
tive eﬀects, including via the paternal line, which is indicative of
an epigenetic mechanism (Dean et al. 2016). Our present demon-
stration that total H3K27me3 was signiﬁcantly increased in
NTera2 cells by exposure to acetaminophen, ibuprofen, or EP2/
EP4 antagonists, when compared with vehicle control, raises the
possibility that alterations in this repressive histone mark in spe-
ciﬁc genes could have occurred. H3K27me3 is highly expressed
and dynamically regulated in fetal GC and is considered impor-
tant in fetal GC diﬀerentiation (Sasaki and Matsui 2008; Seki
et al. 2007). We also showed that analgesics and/or PGE2 antago-
nism decreased expression of one or other of the key methyltrans-
ferase enzymes DNMT3a and DNMT3b in NTera2 cell culture
and of the corresponding genes in in vitro rat culture (testis and
ovary) and in rat in vivo (investigated in ovary only), which
Figure 10. Eﬀect of exposure of pregnant rats to acetaminophen on mRNA expression of epigenetic regulatory genes in fetal testes and ovaries. Pregnant rats
were administered acetaminophen (350 mg=kg once daily), commencing on e13.5, and fetal gonadal tissue was collected on e15.5 or e17.5, 3 h after the ﬁnal
maternal treatment. (A–D) mRNA expression relative to the vehicle cDNA for the same genes after acetaminophen exposure in vivo for e15.5 (A) and e17.5
(B) testes and for e15.5 (C) and e17.5 (D) ovaries (mean± SEM n=7–25). Data were analyzed by two-tailed, unpaired t-test.
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might ﬁt with previous studies linking PGE2 action with DNA
methylation (Huang et al. 2012; Venza et al. 2012; Xia et al.
2012). As fetal GC undergo extensive de- and remethylation dur-
ing perinatal development (Guo et al. 2014; Sasaki and Matsui
2008), analgesic exposure could potentially impact this process
via eﬀects on DNMT expression. The relationship between
analgesic-induced attenuation of PGE2 signaling and its potential
epigenetic consequences in GC, raises the possibility for similar
GC eﬀects of common environmental exposures given that DDT/
other pesticides (Liu et al. 2012; Wrobel et al. 2015), phthalates
(Wang et al. 2010; Romani et al. 2014), bisphenols (Kim et al.
2010), and brominated ﬂame retardants (Park and Loch-Caruso
2015) have all been shown to impact PGE2 production in repro-
ductive tissues.
Our ﬁndings provide circumstantial support for the possibility
that analgesics might induce epigenetic changes in fetal GC in
human pregnancy. Because this possibility cannot be evaluated in
human pregnancy, our diﬀerent model systems could be used to
identify what speciﬁc epigenomic changes are induced in fetal
human GC or NTera2 cells. PGE2 appears to play a consistent
role in modulating key components of the epigenetic regulatory
machinery in fetal gonads and in other tissues (Arosh et al. 2015;
Venza et al. 2012), as well as in numerous cancer cell types
(Venza et al. 2012; Xia et al. 2012), so it may play a similar role
in fetal GC.
Our study has limitations. Although the xenograft and cul-
ture models are relevant to some aspects of normal human fetal
development, including GC proliferation and diﬀerentiation
(Jørgensen et al. 2015; Mitchell et al. 2010; Spade et al. 2014),
none of the models recreate in vivo human conditions. We used
exposures believed to be consistent with therapeutic analgesic
exposures in humans, but we were unable to perform dose–
response studies due to limited availability of human fetal go-
nadal tissue; this should be an important focus of future studies.
Although NTera2 cells derive from TGCC precursor cells,
which are believed to originate from fetal GC (Hoei-Hansen
et al. 2004), they are tumor cells, and not a true fetal GC line.
Despite these limitations, the consistency of the eﬀects of anal-
gesics on GC/NTera2 cell numbers and their concordance
between humans and rats, including in vivo in the latter (Dean
et al. 2016), suggest that the mechanisms involved in analgesic/
PGE2 eﬀects on fetal GC are conserved between rodents and
humans.
In conclusion, the present data suggest that exposure of
human fetal ovaries or testes to therapeutically relevant concen-
trations of acetaminophen and ibuprofen, that reﬂect serum levels
measured in humans following a therapeutic dose of these medi-
cations, causes a consistent decrease in fetal GC number in addi-
tion to eﬀects on gene expression and, potentially, epigenetic
modiﬁcations. These eﬀects are highly reproducible, conserved
in rat and human across diﬀerent model systems, and probably
result from disruption of PGE2 action. Although translation of
our results to human pregnancy has to be considered with cau-
tion, they add to a growing body of evidence concerning potential
eﬀects of analgesics during pregnancy on human developmental
outcomes (Hurtado-Gonzalez and Mitchell 2017; Kristensen et al.
2011; Lind et al. 2017; Mazaud-Guittot et al. 2013; van den
Driesche et al. 2015). This, coupled with the high prevalence of
analgesic use during pregnancy, suggest that prospective studies
to investigate potential eﬀects of analgesic use in pregnancy on
outcomes in oﬀspring should be a research priority. Furthermore,
the potential reproductive/GC eﬀects of analgesic exposure need
to be taken into account in future epidemiological studies associ-
ating chemical exposures in pregnancy and reproductive out-
comes in children.
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